...
首页> 外文期刊>Human Reproduction >Babies born after ART treatment cost more than non-ART babies: a cost analysis of inpatient birth-admission costs of singleton and multiple gestation pregnancies.
【24h】

Babies born after ART treatment cost more than non-ART babies: a cost analysis of inpatient birth-admission costs of singleton and multiple gestation pregnancies.

机译:经过抗逆转录病毒治疗后出生的婴儿比非抗逆转录病毒婴儿成本更高:对单胎妊娠和多胎妊娠的住院分娩成本进行成本分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Currently, about one-third of infants born after assisted reproductive technology (ART) worldwide are twins or triplets. This study compared the inpatient birth-admission costs of singleton and multiple gestation ART deliveries to non-ART deliveries. METHODS: A cohort of 5005 mothers and 5886 infants conceived following ART treatment were compared to 245 249 mothers and 248 539 infants in the general population. Birth-admission costs were calculated using Australian Refined Diagnosis Related Groups and weighted national average costs (2003-2004 euro). RESULTS: ART infants were 4.4 times more likely to be low birthweight (LBW) compared with non-ART infants, translating into 89% higher birth-admission costs (euro2,832 and euro1,502, respectively). ART singletons were also more likely to be LBW compared with non-ART singletons, translating into 31% higher birth-admission costs (euro1,849 and euro1,415, respectively). After combining infant and maternal admission costs, the average cost of an ART singleton delivery was euro4,818 compared with euro13 890 for ART twins and euro54 294 for ART higher order multiples. Findings were not sensitive to changes in casemix. CONCLUSIONS: The poorer neonatal outcomes of ART singletons compared with non-ART singletons are significant enough to impact healthcare resource consumption. The high costs associated with ART multiple births add to the overwhelming clinical and economic evidence in support of single embryo transfer.
机译:背景:目前,全世界约有三分之一的通过辅助生殖技术(ART)出生的婴儿是双胞胎或三胞胎。这项研究比较了单胎和多胎ART分娩与非ART分娩的住院分娩费用。方法:将接受ART治疗后的5005名母亲和5886名婴儿与普通人群中的245 249名母亲和248 539名婴儿进行比较。使用澳大利亚精明诊断相关小组和加权的全国平均费用(2003-2004欧元)计算出生入院费用。结果:与非抗逆转录病毒治疗婴儿相比,抗逆转录病毒治疗婴儿的低出生体重(LBW)可能性高4.4倍,这意味着较高的入院费用(分别为欧元2,832和欧元1,502)。与非ART单身人士相比,ART单身人士也更可能是低出生体重,这意味着入院费用要高出31%(分别为1,849欧元和1,415欧元)。结合婴儿和产妇的入院费用后,ART单例分娩的平均费用为4,818欧元,而ART双胞胎为13,890欧元,ART高倍数为54 294欧元。调查结果对案例组合的变化不敏感。结论:与非ART单身人士相比,ART单身人士的新生儿结局较差,足以影响医疗保健资源的消耗。与多胎抗逆转录病毒相关的高额费用增加了支持单胚胎移植的大量临床和经济证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号